Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study
about
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study.Pathogenesis and treatment of atherosclerosis in lupus.Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.Why are kids with lupus at an increased risk of cardiovascular disease?Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study.Role of Coronary Calcium for Risk Stratification and Prognostication.Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study.Management of cardiovascular risk in systemic lupus erythematosus: a systematic review.Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database.[Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis].Premature coronary heart disease in SLE: can we prevent progression?Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.Lipid Testing and Statin Prescription among Medicaid Recipients with Systemic Lupus Erythematosus, Diabetes Mellitus and the General Medicaid Population.Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
P2860
Q33922922-F3249689-2D93-4785-B31D-FA1E27939804Q37246482-02166819-5DD5-4BBA-AE1B-177B58918F95Q38230699-0D004FC6-96B1-4315-951F-3E4817092402Q38291820-8263ADE4-E692-4A6E-89BB-B4DEA7BC9547Q38554636-3109F225-C6C0-4DF1-8BD4-73B0EB913FA2Q38591752-C81A9089-51A4-4B65-B502-7959FC5E41DEQ38864670-82051FD0-6E56-4CB9-8F82-8A504150E212Q38909471-09968522-23DD-484A-8231-C10952B03149Q38919261-0273FE68-2A5F-41DC-ACDE-69E2FEE85A3FQ39017583-B416874B-99CD-4793-AC6F-5196AC42565DQ39272988-BA1D1031-17B7-422A-88F2-501FF458895AQ39652499-311A2248-4F2D-43D1-8A2B-75E3B661AADBQ41540102-6E1B2417-0FD9-4FB8-8B85-D02F87E38739Q43900414-E15FC4AE-4120-4B99-88B4-C798B1459961Q48274065-99391BF9-5F71-41A8-B063-92C1FF01AF0EQ50052184-CF3D96F2-EB8B-4BC2-A9E2-F218CC184BB7Q52592135-1E3A1E85-13AF-40F6-AFB7-824E5646C5E4Q54324843-7F921CB8-2FBC-4373-8D50-AE765FBB0298
P2860
Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Influence of atorvastatin on c ...... sked, placebo-controlled study
@ast
Influence of atorvastatin on c ...... sked, placebo-controlled study
@en
type
label
Influence of atorvastatin on c ...... sked, placebo-controlled study
@ast
Influence of atorvastatin on c ...... sked, placebo-controlled study
@en
prefLabel
Influence of atorvastatin on c ...... sked, placebo-controlled study
@ast
Influence of atorvastatin on c ...... sked, placebo-controlled study
@en
P2093
P2860
P356
P1476
Influence of atorvastatin on c ...... sked, placebo-controlled study
@en
P2093
Hanna Dziedzic
Jacek Musial
Krzysztof Gryga
Lidia Tomkiewicz-Pajak
Malgorzata Konieczynska
P2860
P2888
P356
10.1186/AR3402
P577
2011-07-20T00:00:00Z
P5875
P6179
1008891329